Indirect Pulp Capping Versus Pulpotomy With MTA for Treatment of Primary Molars With Deep Caries

Minia University

Status: Active, not recruiting

Conditions: Indirect Pulp Capping; Pulpotomy

Treatments: Combination Product: MTA

Study type: Interventional

Funder types: Other

Identifiers

NCT05554952

526_1 /11/2021

Details and patient eligibility

About

The aim of the current randomized controlled trial is to evaluate clinical and radiographic outcomes of indirect pulp capping and pulpotomy with MTA in treatment of primary teeth with deep caries over a 12-month follow-up period.

Full description

Output patients coming to Pediatric dentistry department Minia University, selected randomly to evaluate clinical and radiographic outcomes of indirect pulp capping and pulpotomy with MTA in treatment of primary teeth with deep caries over a 12-month follow-up period an equivalent parallel randomized controlled trial

Enrollment: 100 patients

Sex: All

Ages: 3 to 6 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• • 4 to 6 years old patients presented with deep carious lesions in primary molars.
• Apparently healthy children (ASA I, II classification).
• Co-operative children (Rating 3 & 4 according to Frankle classification)

Exclusion criteria

A) Clinical:

• Non restorable primary molars.

• Presence of clinical pathology.

• Presence of mobility or tenderness to percussion.

  • Spontaneous pain.

B) Radiographic:

• Pre-operative radiographs showed external or internal root resorption.
• Presence of furcal radiolucency.
• Presence of periapical radiolucency or widened periodontal ligament space
• More than one-third root resorption detected.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

100 participants in 2 patient groups

Group 1

Active Comparator group

Description:

Indirect pulp capping with MTA

Treatment:

Combination Product: MTA

Group 2

Active Comparator group

Description:

Pulpotomy with MTA

Treatment:

Combination Product: MTA